Jonsson-Oldenbuttel C, Ghosn J, van der Valk M, Florence E, et al. Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical Settings. J Acquir Immune Defic Syndr 2024;96:472-480.
PMID: 38985445